REVIEW ARTICLE
Inhibition of PPARγ by Natural Compounds as a Promising Strategy in Obesity and Diabetes
Alessandra Ammazzalorso*, Rosa Amoroso
Article Information
Identifiers and Pagination:
Year: 2019Volume: 13
First Page: 7
Last Page: 15
Publisher ID: TOMCJ-13-7
DOI: 10.2174/1874104501913010007
Article History:
Received Date: 06/11/2018Revision Received Date: 26/01/2019
Acceptance Date: 04/02/2019
Electronic publication date: 28/02/2019
Collection year: 2019
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
A wide group of natural compounds (flavonoids, stilbenes, neolignans and others) has been identified as Peroxisome Proliferator-Activated Receptor (PPAR) agonists, with a large variety of chemical structure and different activity versus the three PPAR subtypes. These receptors are transcription factors controlling metabolic pathways in the organism, involved in lipid and glucose metabolism, cell differentiation and energy homeostasis. Otherwise, very little is known about natural compounds able to inhibit PPARs. A number of studies demonstrate that PPARγ repression has a beneficial effect in reducing body weight and improving insulin sensitivity, suggesting a potential clinical role in obesity and type 2 diabetes. This review analyzes natural compounds able to repress PPAR activity and their potential use in metabolic disorders.